KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
INTERESTING COMPANY (Please tick the lists you are interested in)
(List dated : Feb. 24, 2015)
No.
1
Company Name
AHN-GOOK PHARMACEUTICAL
COMPANY LTD.
Business
Focus
Incrementally
modified drug
Main Products
Homepage
√
www.ahn-gook.com
□
www.bexpharm.com
□
www.boryung.co.kr
□
www.buminsa.com
□
www.criver.co.kr
□
Main Products
1. Letopra tablet (S-pantoprazole)
2. Olmos-F tablet (Olmesartan cilexetil)
3. Synatura syrup (Ivy leaf extract + coptidis rhizoma)
4. Anycough capsule (Theobromine)
5. Acefenac CR tablet (Aceclofenac)
R&D Pipeline
1. SAV301 / S-project / Antihypertension
2. AG SCT101 / S-project / Antihypertension
3. Rupatadine / NCE / Allergic rhinitis
4. AG AK903 / Natural Product / Periodontal disease
5. AG NRF / Natural Product / Nephritis Remedies
Company Introduction
BexpharmKorea Ltd. seeks to maintain client-centered management
with respect for human beings.
Ever since the foundation of the company in 2001, we have been
offering high quality customer satisfaction and convenience to keep
our continued and close relationship with the customers. New
medicines are being introduced but there is lack of supply for the
demand. We continue to excel in providing appropriate care for the
patients without cure or appropriate cure available.
We BexpharmKorea will provide top quality products with excellent
service to provide value that you deserve and we are reaching for the
top with the creativity, providing finest customer satisfaction, and
we're will be a beautiful company to you always
Pharmaceuticals Importer /
Distributor, OEM
2
BEXPHARM HEALTH CARE
Medical Device :
Manufacture,
Importer /
Distributor
Logistics :
Fresenius Medical
Care Korea
Partnership
Main Products
• Exclusive Products in Korea
Trade name
Composition
Provider
Lactitol powder
Laxative, Hepatic
encephalopathy
yuhan Pharmaceuticals
Portalac syrup
Prebiotics, For the
Treatment of Consitpation
DuPont Danisco. U.S.A
Inc
Menoferil
Selective Estrogen
Receptor
Modulator(SERM)
Dawon Pharmaceuticals
Hepasphere
Microspheres
Hepatic TACE
MeritMedical.U.S.A
Embosphere
Microspheres
Myoma of the uterus
MeritMedical.U.S.A
Epiceram
Skin barrier repair therapy
PuraCap
Pharmaceutical U.S.A
Flaminal
Enzyme alginogel protects
the wound
Flen Pharma , Belgium
Physiodose
Physiological saline
solution
Gilbert, France
RepHresh
Vaginosis
Lil Drug product Inc.
Replens
Vaginal Dryness
Lil Drug product Inc
• Others : Distribution of some Imported & Local Products
3
BORYUNG PHARMACEUTICAL
CO., LTD.
CVS, CNS,
Oncology
Company Introduction
Boryung Pharmaceutical Co., Ltd founded in 1963, has put a
strong presence in Korean market as one of TOP leading
pharmaceutical companies. Boryung has invested continually on
research and development and made continuous efforts to produce
high-quality products in the specialty areas such as cardiovascular,
antineoplastic and antibiotics drugs. Boryung has developed
Kanarb(Fimasartan), an innovative anti-hypertensive drug that has
been approved by the KFDA as the 15th new drug, also it is 8th
new ARB drug in the world. It has been licensed-out in 16
countries including Mexico, Brazil, Russia & China worth the
amount of $200 million and we are continuing to expand the global
network to reference countries such as USA, EU, Japan and the
pharmerging markets (ASEAN, Middle East, and Africa etc.)
Main Products
1. Kanarb (Innovative Anti-Hypertensive Drug)
2. Buspar (Buspirone)
3. Taxol (Paclitaxel)
4. Astrix (Aspirin)
5. Megace
6. Meiact (Cefditoren)
7. Gelfos M
4
BUMINSA
5
CHARLES RIVER
LABORATORIES KOREA
Cleanroom
subsidiary materials Cleanroom subsidiary materials and consumables
and consumables
CRO
Company Introduction
Charles River helps our global partners with high-quality research
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
models and services; discovery, preclinical and clinical support; and
endotoxin products and services, microbial identification services.
Our portfolio spans the entire research and drug development
process, with flexible approaches for any program size. Charles
River Laboratories Korea has been providing Discovery/Preclinical
services, endotoxin products and technical support service. In
addition, Charles River Korea has been also providing Microbial
Identification services compliant to cGMP for Asia Pacific clients
since September 2013.
Main Products
1. Rapid Endotoxin Testing
Charles River’s rapid endotoxin testing systems, the Endosafe®PTS™ and Endosafe®-MCS™, utilize FDA-licensed test cartridges
to provide results on-site in just 15 minutes. Endosafe® Nexus™
which is the first fully automated robotic system designed
specifically for endotoxin testing in the central QC lab, it is ideal for
high-volume water testing or samples that require dilutions.
2. Microbial Identification Services>
AccuGENX-ID® is our identification service utilized DNA
Sequencing of the 16S ribosomal RNA(rRNA) gene in bacteria and
ITS2 rRNA region in fungi, recognized as the most accurate and
reproducible method for identifying unknown organisms. And
AccuPRO-ID® is a first-in-industry polyphasic approach to microbial
identification utilizing proteotypic MALDI-TOF technology.
Main Products
1. Lipilou(Atorvastatin) is our top selling product with sales of about
$33m. This is the highest among all (generic) products of atorvastatin
except Lipitor by Pfizer.
2. Tacrobell(Tacrolimus) has enabled to smoothly absorb tacrolimus
in GI tract by improving the bioavailability using our novel solid
dispersion technology.
3. Cipol-N(Cyclosporine Microemulsion) has been produced by our
own technology, awarded for ‘KT mark’ meaning the excellent
Korean technology.
4. Telminuvo(Telmisartan and S-Amlodipine) effectively reduces
blood pressure in hypertensive patients. It has become one of our
major products since its launch in April 2013.
5. Pregrel(Clopidogrel Resinate), a new salt form of clopidogrel, has
shown to be more stable and highly safer than Plavix that is
susceptible to degradation.
6
CHONG KUN DANG
PHARMACEUTICAL CORP.
R&D Pipeline
1. CKD-732 is the first-in-class compound targeting methionine
aminopeptidase-2. It reduces the production of fatty acid and helps to
Cardiovascular and convert stored fats into useful energy. Phase IIa for severe obesity
metabolic disease, was completed by Zafgen, our licensed partner in the US.
Oncology,
2. CKD-516 disrupts the formation of blood vessel around the tumor
Immunology
by inhibiting tubulin polymerization. It is applicable to a variety of solid
tumors. Phase I is ongoing with the National OncoVenture.
3. CKD-519, as a novel therapy for the dyslipidemia, remarkably
raises HDL cholesterol and improves lipid profile through inhibiting
CETP. Phase I will be initiated in 2014.
4. CKD-841 is a novel sustained release formulation of Leuprolide
using our proprietary technology, the injectable Liquid-Crystal
system, which can be applied to a wide range of drugs including
peptide and proteins, superior to well-known PLGA microparticle
injections. Phase I will be initiated in 2014.
5. DC-002 is a novel HDAC6-selective inhibitor in preclinical stage for
treating various autoimmune diseases. It is expected to show a
superior safety and efficacy profile to other competitors.
www.ckdpharm.com
□
http://cbfez.go.kr
□
New Active Substances
1. Camtobell, our first new chemical drug, has an effect on patients
with ovarian and small cell lung cancer through the inhibition of
topoisomerase I. Sales of Camtobell were about $2m.
2. Duvie, a selective PPAR-gamma agonist, is a novel anti type2
diabetic therapeutics commercialized in Korea in February 2014.
Duvie is safe from cardiovascular risks by improving lipid profile.
7
CHUNGBUK FREE ECONOMIC
ZONE AUTHORITY
Introduction
The BioValley in Osong will be developed into a mecca of nextgeneration, new biotechnology drug industries and ICT convergence
medical device industries, while Aeropolis around Cheongju
International Airport will be an aviation complex incorporating aircraft
MRO, passenger transportation, logistics and shopping.
Furthermore, Ecopolis in the Chungju region will transform into a
biological recreational and automotive electronics industrial park.
The CBFEZ will reward your investment with confidence and tangible
results, offering the geographical advantage of the center of Korea
and Northeast Asia as well as optimal operational environments
including quality transportation and logistics infrastructure.
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
Company Introduction
Since CJ HealthCare was established in 1984, the company has
taken firm leadership in the local pharmaceutical market thanks to
its product lineup of ethical (ETC) drugs such as anticancer,
circulatory system, diabetes, and kidney disease treatments and
over-the-counter (OTC) drugs. We have also acquired Hanil
Pharmaceutical in 2004, reinforcing our competitive edges in the
pharmaceutical market. CJ HealthCare was designated as an
'Innovative Pharmaceutical Company' by the Ministry of Health and
Welfare in 2012.
8
CJ HEALTHCARE CORP.
Main Products
• Epokine (Erythropoietin-α)
Epokine®, the Most Reliable Choice for Renal Anemia – Developed
1st in Korea and 3rd in the world Epokine® is safe and effective in
ETC(CVs,
treating anemia of hemodialysis patients with end-stage renal
Antibiotics, IV
Solution, Oncology, disease (Phase Ⅲ clinical study)
Endocrinology,
• Leukokine (Filgrastim)
Nephrology &
Urology, Gastro
Leukokine® has the same efficacy and safety with those of the
Intestinal, Musculo control on neutropenia
skeletal,
- For the Neutropenia Induced by Chemo therapy in Advanced
Respiratory,
Cancer Patients
Others), OTC
- For the Neutropenia Induced by Chemotherapy in Acute Leukemia
Patients
www.cjp.co.kr
□
www.clpharm.com
□
www.cmgpharma.co.kr
□
www.daewonpharm.com
□
• Tapocin® (Teicoplanin)
Tapocin® is the first choice for the treatment of MRSA,
MRSE and Enterococcus
1. Excellent antibacterial effects on MRSA, MRSE and
Enterococcus
2. Once-daily dosing
3. The Efficacy and Safety proved by clinical trial
• Vancorin® (Vancomycin)
Vancomycin® is the best choice for MRSA & MRSE.
- Reliable supplier of vancomycin injection for over 10 years
- A proven Efficacy and Safety on Asian people
9
CLPHARM
Film-type drugs,
OTC, Health
functional food
Company Introduction
Through 13 years of continuous research and development on ODF
film technology, CLPharm developed own equipment (patent hold)
and manufacturing product with it. CLPharm was also certified its
ompetitiveness through many certificates like INNO-BIZ, Venture
company, IP star company, technology patent, ISO 9001, ISO 14001
and KGMP. CLPharm grafted Flavor Encapsulation technology and
Drug Delivery System onto original technology of edible film
production that would higher drug compliance on enfant, child, elderly
and infirm who have trouble in swallow pills. CLPharm owns
technology that can be applied on various fields from functional food
to medication and we are sole enterprise in the world with this
specialized technology.
Main Products
“Hemoramin”, film type iron and folic acid supplement.
“Ramea”f ilm type antiemetic medication.
“Ignis”, film type Erectile Dysfunction medication.
12
11
CMG PHARMA
DAEWON PHARM. CO., LTD.
Tadalafil OTF,
Aripiprazole OTF,
Entecavir OTF etc.
Synthetic / Herbal
Medince / DDS
To be updated
Pelubiprofen Tab. (New Chemical Entity)
• Composition : Each tablet contains Pelubiprofen 30mg
• Indications : Reduce symptoms of Osteoarthritis, Rheumatoid
arthritis and Back pain.(Lumbago)
• Dosage & Administration : 1 tab.(30mg), 3 times daily after meals.
1. Pelubiprofen demonstrates outstanding efficacy for osteoarthritis
and back-pain (lumbago), and rheumatoid.
2. Pelubiprofen is prodrug type which has strong analgesics and antiinflammatory efficacy through absorbed and then transferred to
active metabolties. The safety was also demonstrated through the
result of clinical studies.
3. SR (Slow release) Tab. is also under development and planned to
be released in 2015.
Megestrol Acetate Susp. (800mg/20mL) / ES Susp.(625mg/5mL)
Megestrol Acetate is indicated for the treatmentof anorexia, cachexia,
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
or an unexplained, significantweight loss in patients with AIDS or
cancer.
Freefol-M Inj. (1 vial, propofol 10mg/mL)
MCT/LCT- drug carrier emulsion
- Pain caused from injection is significantly decreased.
- Optimization in Lipid metabolism. / No effect in respiratory system.
Wontran SR Tab. (Acetaminophen 650mg + Tramadol 75mg)
Wontran SR Tab. is slow release formulation of Janssen Ultracet Tab
Moderate to moderately severe Pain / 1~2 Tab. every 12 hours
12
Company Introduction
Daewoong has the largest prescription drug sales in Korea and
envisions itself to become a top 50 global healthcare company by
2015. In addition, Daewoong has built strong core competency for
new drug development and has cultivated a cooperative culture for
collaboration with global partners. In the future, Daewoong will
expand its global business with its foreign branches and partners
Biosimilar , New
and become a global healthcare group which contributes to
DAEWOONG PHARMACEUTICAL
Drug for Alzheimer improving the quality of life for people worldwide.
CO., LTD.
& HBV
Main Products
We are a leading manufacturer of Ursodeoxycholic acid (UDCA /
Ursodiol)
- Compliance with global standards : EP, USP, JP, BP, KP
Meropenem
- Compliance with global standards : EP, USP, JP Lansoprazole,
Rabeprazole, Cefotiam, Valsartan, etc.
www.daewoong.com
□
www.dong-wha.co.kr
□
www.donga-st.com
□
www.dongwookr.com
□
Main Products
- Clozapine
Strength : 25mg , 100mg
- Olanzapine
Strength : 5mg , 10mg
- Amlodipine / Valsartan
Strength : 5mg/80mg , 5mg/160mg , 10mg/160mg
- Rebamipid
Strength : 100mg
- Glimepiride / Metformin hydrochloride
Strength : 1/250mg , 2/500mg
13
DONG WHA PHARM. CO., LTD.
NCE
R&D Pipeline
- Zabofloxacin(DW224)
indication : Antibiotics
Status : Phase III
Characteristic & Merit
• Gram (+) resistant bacteria, respiratory tract infections, particularly
pneumoniae
- DW1029M
indication : Diabetic nephropathy
Status : Phase II
Characteristic & Merit
• New herbal drug
• Microalbuminuria
• Safety & low side effect
- DW2006
indication : Allergic rhinitis
Status : Phase II
Characteristic & Merit
• New herbal drug
• efficacy in wide range of
• Safety & low side effect
immune diseases
Company Introduction
Dong-A ST focuses on ethical drugs, such as domestically developed
new drugs like Stillen, Zydena, and Motilitone, medical devices,
diagnosis, and overseas business.
With its optimized research infrastructures such as its world-class,
sophisticated research center completed in 2011, as well as its
excellent researchers, Dong-A ST is furthering its efforts to develop
global new drugs. Also, with the backing of these infrastructures,
Dong-A ST vows to positively explore overseas markets, to expand
its overseas exports, and to establish itself as a global
pharmaceutical company, operating beyond the domestic market.
14
DONG-A ST
Pharmaceutical
Main Products
1.EPORON
2.GROWTROPIN
3.ZYDENA
4.CLOSERIN
5.MONOTAXEL
6.LEUCOSTIM
7.GONADOPIN
8.STILLEN
9.GEMCIT
10. CIRCULAN
15
Company Introduction
DongWoo is a fast growing API synthetic company operating under
API, Intermediates,
WHO-GMP guidelines. DongWoo is a R&D focused company with its
DONGWOO SYNTECH. CO., LTD.
Chemical and
researches covering not only on the development of cost-effective
Nutritional Products
and innovative processes but also on new substances. As result of
R&D efforts, DongWoo has applied for many of crystalline and
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
process patent and is participating in several government technology
development project including Nano technology for Anti-diabetics.
DongWoo Syntech has also received approval for many KDMF
products by Korea FDA and has applied CEP / EDMF for several
APIs in Europe market as well as JD MF for Japan market.
In addition to the DMF fillings, DongWoo has received audit by
independent auditor from European country with success. Also
recently inspected and approved by PMDA Feb,2014. DongWoo
Syntech has been certified as a“Venture company”and“INNO BIZ
Company”by Korean government authorities. DongWoo is always
ready to discuss contract manufacturing of API as well as
intermediate business as your good partner.
Main Products
Rebamipide, Temocapril HCl, Butenafine HCl, Terbinafine HCl,
Naftopidil, Glimepiride, Mosapride, Voglibose, Pioglitazone HCl
Company Introduction
As the market leader in the antiobesity field, DreamPharma is the
manufacturer of Furing (our first proprietary product approved by the
KFDA), Panbesy (an effective 30mg sustainedrelease pill), and
nutritional dietary supplements, such as Multivitamin Phyto and
Cytrics C. Starting business in 1996 as Hanwha Co., Ltd.,
Pharmaceutical Business Division, DreamPharma has realized its
vision of "Enhancing the Quality of Life" by developing Prescription
Drugs.
16
17
DREAM PHARMA CORP.
ENZYCHEM LIFESCIENCES
CORPORATION
Pharmaceutical
APIs
Main Products
• Antihistamines : Estina Tablet
• Pain : Iburos Tablet
• Gastrointestinal : Spasmex
• Respiratory : Theoclear Cap.130mg
• Circulatory : Dusoril Cap.
• Dermatology : Astart Cream
• Antiobesities : Arbol Cap.
• Injection : Hiloneed Inj.
• Others : Colonlyte Powder 2L
Company Introduction
Enzychem Lifesciences Corporation is a Global New Drug
Development Venture that was founded on the most advanced life
sciences and technologies of medicinal chemistry in July 1999. With
its Global New Drug R&D center located in KAIST in Daejeon and its
two GMP manufacturing plants in Jecheon, it has since been
developing and producing APIs and functional health foods, and
developing global new drugs as the leader of the field.
Enzychem Lifesciences is an innovative enterprise marketing APIs
both domestically and overseas. It has developed global new drugs to
treat chemotherapy-induced neutropenia, chemotherapy-induced
thrombocytopenia, sepsis, cancers, and autoimmune disorders that
uses EC-18 (PLAG, a substance naturally duplicated from deer
antlers). It also owns dozens of intellectual properties with regard to
the processes and uses of EC-18 and the processes of 1st generic
pharmaceutical ingredients and produces APIs meeting EU GMP
quality standards thanks to its state-of-the-art GMP facilities for
synthetic process. In addition, after its first GMP plant (specializing in
the production of cephalosporin), it completed its second GMP plant
(specializing the manufacture of non-cephalosporin) in October 2012.
It is now pushing for the production of not only cephalosporin but also
non-cephalosporin and functional health products enhancing
immunomodulation. Enzychem Lifesciences makes all its efforts to
become a global biopharmaceutical firm that "develops global new
drugs that understand and fulfill the unmet needs of patients, that
develops new drugs that meet patients' indispensable yet unfulfilled
medical needs, and that contribute to the health and happiness of
humanity" under the towering mission and motto that "We save
human lives one at a time."
www.dreampharma.co.kr
□
www.enzychem.com
□
http://eng.greencross.com
□
Business
• Global New Drug : EC-18, a blockbuster of an oncology drug
• Health Food Rockpid : Rockpid, made by PLAG, The mystery of
2000-year deer antlers naturally duplicated by modern sciences is
based
• APIs (Active Pharmaceutical Ingredients) : Production & Sale of
APIs
18
Green Cross Corporation
Company Introduction
Green Cross is an exemplary R&D-oriented company that leads the
biotechnology industry in Korea. Starting from the nation’s first
production and sales of Plasma Fractions in 1970, which required
sophisticated technology, Green Cross has striven to develop ethical
drugs that are hard to produce but essential to patients.
Subsequently, it is now an internationally recognized biotechnology
company in the fields of plasma fractions and vaccine.
• 1974-Started manufacturing the AHF, and antihemophilic factor
• 1983-Succeeded in developing the world’s third Hepatitis B vaccine
Biological Products
after 12 years of study
• 1988-Succeeded in developing the world’s first vaccine against the
epidemic hemorrhagic fever (Hantavax)
• 1989-Mogam Biotechnology Research Institute was designated by
the WHO as a partner research institute
• 2011-The influenza vaccine GC FLU became the fourth in the world
to obtain Pre-Qualification approval from the WHO
Main Products
• Human Serum Albumin
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
• Human Intravenous Immunoglobulin
• Human hepatitis B Immunoglobulin
• Human Tetanus immunoglobulin
• Varicella Zoster Immunoglobulin
• Human Blood Coagulation Factor vlll
• Recombinant Coagylation Factor vlll
• Split Virion Unactivated Influenza Vaccine
• Live Alltenuated varicella Vaccine
• Inacivated Japanese Encephalitis Vaccine.
Main Products
• APITOXIN Inj. (Dried Honeybee Venom 1mg)
• NEWLAXON Inj. (Ceftriaxone sodium 1g)
• Disolin Inj. (MethylPrednisolone sodium succinate 40mg)
• Figure-S Cab. (Green tea extract 375mg)
19
GUJU PHARM. CO., LTD.
Production
and Sale of
Medicines
R&D Pipeline
www.gujup.co.kr
□
www.hanlim.com
□
www.hanmipharm.com/eng/
□
• Anti-obesity agenting botanical drug MINI (Code name) (Phase II
completed)
• Anti-fatty liver botanical drug (early stage)
• New-liver function improved drug
• New form or improved form of approved drugs
Main Products
• Naidipine tab.
API : Amlodipine
Indication : Anti-hypertensive
Partner : Ildong / Daewoong
Clinical Study : Phase 1
Remark : New salts
• Lodien tab.
API : S-amlodipine nicotinate
Indication : Anti-hypertensive
Partner : Shinpoong
Clinical Study : Phase 1, 3, 4
Remark : Chiral / New salts
20
HANLIM PHARM. CO., LTD.
Pharmaceutical
• Risenex Plus tab.
API : Risedronate + Vit D3
Indication : Anti-oesteoporosis
Partner : Daewoong / Pacific
Clinical Study : Phase 3, 4
Remark : New combination (once a week)
• Risenex M tab.
API : Risedronate + Vit D3
Indication : Anti-oesteoporosis
Partner : Hanmi
Clinical Study : Phase 1, 3, 4
Remark : New combination (once a week)
• Nasaflex nasal spray
API : Mometasone furoate / Azelastine HCI
Indication : Allergic rhinitis
Partner : Hanmi
Clinical Study : Phase 3, PMS
Remark : New combination
Finished Products (CTD completed)
Amlodipine+Losartan Tab.
Strength : 5/50mg, 5/100mg, 10/50mg
Esomeprazole Cap.
Strength : 20mg, 40mg
Naproxen+Esomeprazole Tab.
Strength : 500/20mg
Clopidogrel Cap.
Strength : 75mg
21
HANMI PHARMACEUTICAL CO.,
LTD.
NCE
Ceftriaxong Inj.
Strength : 250mg, 500mg, 1g, 2g
Sodium Hyaluronate Inj.
Strength : 20mg in 2ml
API (2 API Plants)
Cephalosporin API
-Cefotiam HCI
-Ceftizoxime sodium
-Ceftazidime for Inj.
-Cefixime -Irbesartan
-Ceftriazone
-Cefotaxime
22
HAPPY CALL CO., LTD.
Cosmetic
Ingredients, API
General API
-Montelukast
-Pregabalin
-Pioglitazone
-Telmisartan
-Hyaluronic acid
Company Introduction
Happy-call, established in 1997 with the spirit of faith and sincerity,
has been growing up as a distributor of raw materials in cosmetics
and pharmaceutical industry. We promise our customers that we will
offer one-stop service on every kind of permission of import/export
Main Products
1. Raw materials of Cosmetics and pharmaceuticals
□
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
2. Related products
Main Products
1. EYE DROP (ETC, KYNEX 2 EYE DROPS)
2. DENTAL CARTRIDGE (ETC, LOCAL ANESTHETIC-LIDOCAINE)
3. ALLOON TAB (OTC, ANTI-OBESITY)
4. ELARVIE (MEDICAL DEVICE, SODIUM HYANULONIC ACID)
5. MERIT C ACID (DIETARY SUPPLEMENT, VITAMIN C)
23
HUONS CO., LTD.
TOTAL HEALTH
CARE
R&D Pipeline
1. BOTULINUM TOXIN TYPE A (HUTOX, PRE-CLINICAL,
TEMPORARY IMPROVEMENT OF GLABELLAR LINES)
2. MAGNOLIAE CORTEX EXTRACT (HU002, PHASE 2, FATTY
LIVER)
3. CYCLOSPORINE 0.05% (PAHSE 3, DRY EYE SYNDROME)
4. CLOPIDOGREL 75MG + ASPIRIN 100MG (ARIGREL ACP,
ARTERIOSCLEROSIS)
5. NENOMA TAB (CLOMIPRAMINE 15 MG, PREATURE
EJACULATION)
6. CLOMIPRAMINE 15MG + SILDENAFIL 100MG (PHASE 1,
PREMATURE EJACULATION + ERECTILE DYSFUNCTION)
7. AMLODIPINE CAMSYLATE 7.84MG + LOSARTAN POTASIUM
100MG (LOCATAN TAB, ARTERIOSCLEROSIS TREATMENT)
www.huons.co.kr
□
www.ilyang.co.kr
□
www.immunemed.co.kr
□
www.jeilpharm.co.kr
□
www.jw-pharma.co.kr
□
New Active Substances
1. MAGNOLIAE CORTEX EXTRACT (HU002, PHASE 2, FATTY
LIVER)
2. CYCLOSPORINE 0.05% (PAHSE 3, DRY EYE SYNDROME)
24
IL-YANG PHARMACEUTICAL
CO., LTD.
Urology, GI,
Dermatology
New chemical
Entity
Company Introduction
Under the corporate philosophy of "Value Creation with Respect for
Man's Life and Dignity", IL-YANG PHARM was established in 1946
and stepped forward with the growth of Korean pharmaceutical
industry. Having founded organic raw material composition plant in
1983 and GMP plant in 1985, we modernized our production facilities
and released 'Ganoderma Lucidum Youngbichun Drink', being the
leader in the nutrient tonic market. Later with a great ambition, ILYANG started to develop new material as of 1986 and invested
considerable profits from Wonbi-D and Youngbichun in a search for
epoch-making cures and new medicine development. Particularly,
'Ilaprazole', the next generation medicine for gastric ulcer, obtained
patents in USA and Japan, enabling continued investment in research
and development. For now, Chairman Chung Do-oen and CEO Kim
Dong-yeon is building up adamant corporate culture through continued
management innovation and carrying out aggressive investment in
research and development. IL-YANG is now preparing for future with
an aim to become the best global pharmaceutical company. With the
start of 'No. 14 Noltec(Ilaprazole)', so-called next generation's antiulcer
medicine, we are developing 'Supect', a super leukemia medicine and
expanding into the field of vaccination business and BIO medication.
Main Products
[Finished Products]
1. Dried Aluminum Hydroxide Gel Power
2. Aluminum Hydroxide Gel
3. Aluminum Hydroxide –Magnesium Carbonate Co-dried Gel
4. Magnesium Trisilicate Power
5. Magaldrate
6. Dried Aluminum Phosphate Gel
7. Hydrotalcite
25
Company Introduction
ImmuneMed Inc. promises to become a world-trusted company
based on creative high-tech intensive research and sound
management. Our mission is on human health and welfare in terms of
the treatment of incurable or obstinate diseases. We believe that the
human immune system itself is the most effective defense system of
our body in curing various infectious diseases. These beliefs have
been a guiding principle for our research over the years. Using the
innate immune system, a new antiviral cytokine has been developed
and the research has been done using various techniques,such as
virus culture, protein purification, RT-PCR,gene cloning, ELISA,
MALDI-TOF protein expression in conjunction with animal
experiments. In addition, we are also developing diagnostic kits using
lateral flow immunochromatographic assay for early detection of
acute febrile illnesses such as Scrub typhus, Lepospirosis,
Hemorrhagic fever with renal syndrome, and a Murine typhus.
IMMUNEMED INC.
Main Products
Leptospira RAPID
Scrub Typhus RAPID
Hanta RAPID
Murine Typhus RAPID
AFI RAPID
26
27
JEIL PHARMACEUTICAL CO.,
LTD.
JW PHARMACEUTICAL
CORPORATION
Pharmaceutical
Anti Cancer,
Formulation
research
1. Kefentec Plasta
3. Yamatetan
5. Omnicef
7. Lanston
9. Gastrex
2. Stablon
4. BUP-4
6. Berasil
8. Cravit
10. Inhibace
Company Introduction
Since its foundation, JW Group has led the hospital market based
on respect for life and the pioneering spirit, and is now being reborn
as a global healthcare company to lead the industry into the 21st
century. Based on leading competitiveness in the ethical drug
market, JW Pharmaceutical has built up strong sales network across
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
the country and superior pipelines in I.V solutions, antibiotic,
cardiovascular, gastrointestinal, nephrology, anticancer and
neuropsychiatry. And now, it is pioneering the rapidly growing new
field such as diabetes and so on. It has been striving to produce and
provide innovative new technologies and services heading for
healthy lives of human beings on the basis of its founding spirit of
“Respect for life”.
Main Products
• Carbenem Antibiotics
• Antifungal Agents
• Anticancer drugs
• I.V Solutions
• Other antibiotics
28
KGCYEBON
Natural API CMO /
Health Functional
Food Raw Material
OEM, ODM
To be updated
www.kgcyb.co.kr
□
http://kmbiz.com
□
www.kup.co.kr
□
www.lgls.co.kr
□
www.lskglobal.com
□
Main Products
• Perpak
We consult and support you to properly apply sterile packaging
materials and a total of 3,000 kinds of products for a clean room to
various certifications(KGMP&etc.) at Bio/ Pharmaceuticel industry.
29
• CleanQplus (www.cleanqplus.com)
CleanQplus is on-line shopping mall to provide cleanroom and safety
supplies for companies and laboratories. We have supplied more
than 3,000 kinds of products with the reasonable quality and price to
enhance the value of the customer.
KM CORP.
• Savillex products / Gore Sealants / Wada
Savillex products are used in laboratories involved in analyses of all
types in every step from gathering the sample to analyzing the
sample. Gore Sealants are among the world’s tightest chemicallyresistant gaskets. Wada have supplied the clean pressurized
canisters to the needs of Fine chemical, Pharmaceutical,
Food/Beverage industry
Main Products
• Clanza CR tabs.
World Only One, Once Daily aceclofenac
Best in NSAIDs in terms of Safety & Effectiveness
Launched in Korea, Vietnam, Philipine
On registering in Russia, Kazakhstan, Ukraine, Venezuela, China
30
KOREA UNITED PHARM. INC.
NME, IMD, Generic
drugs & Other
Healthcare
Products
• Clavixin Duo caps.
Combined Product of Clopidogrel and Aspirin
Filled with Clopidogrel granules(IR) and Aspirin
Less undesirable effects
Launched in Korea
• Cilostan CR tabs.
The World One and Only Cilostazol CR 200mg
Less side effects of headache & tachycardia
Improved patients' compliance - One tablet Once daily
Launched in Korea
On registering in China
Company Introduction
LG Life Sciences began research in genetic engineering in 1981
and has invested steadily in the life sciences ever since. This effort
has already resulted in world-class technology and product
capabilities. The company has focused R&D resources and knowhow on three areas-pharmaceuticals, animal health and specialty
chemicals.
31
LG Life Sciences has developed and commercialized an array of
pharmaceuticals over the years. These include interferon in 1989
(Intermax-gamma) and 1992 (Intermax-alpha), hepatitis B vaccine in
1992 (EUVAX B™), human growth hormone in 1993
(EUTROPIN™), degenerative arthritis treatment in 2005 (HYRUAN
Plus™), rhFSH (recombinant human follicle stimulating hormone) in
2006 (Follitrope™), and SR-hGH (Sustained Release-human
Growth Hormone) in 2007 (Declage™). A company milestone was
reached in 2003, when its next-generation quinolone antibiotic
(FACTIVE®) was approved by the FDA in the United States.
LG LIFE SCIENCES LTD.
LG Life Sciences has succeeded in animal health products including
the 1994 commercialization of recombinant bovine somatotropin
(BST, product name BOOSTIN®). The product, which is used to
increase milk production in lactating dairy cows, has achieved the
top share in numerous national markets. In 2006, LG Life Sciences
has also launched a bovine mastitis vaccine (MastaVac) that
reduces the number of somatic cells, relieving clinical symptoms in a
cow that has been infected with mastitis.
As for specialty chemicals, LG Life Sciences completed in-house
development of Korea's first new herbicide (PYANCOR®) for rice in
1997 and fungicide (GUARDIAN®) for use in horticulture in 1999. A
new herbicide (FLUXO®) for both pre- and post-emergence rice was
completed in 2004.
32
LSK GLOBAL PHARMA
SERVICES
CRO SERVICE
Company Introduction
LSK Global Pharma Service is the highest quality contract research
organization (CRO) that can be sought out. Founded in March of
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
2000, LSK Global PS has since been making an extensive effort to
provide clinical trial services that meet global standards. We
perform clinical trials based on SOPs (drafted in English) which
strictly follow ICH-GCP guidelines in order to improve clinical trial
quality, and we are using a system to meet international standards.
Scope of Service
• General Consulting
- Regulatory Strategy Consulting
- Bridging Study Strategy
- Study Design Consulting
- Product Development Consulting
• Monitoring
- Monitoring (SIV, IMV, COV, Query Resolution etc.)
- Documentation (Collection and Maintenance of TMF / ISF / PF)
- Safety Management
- Site Management
• Medical Writing & Research
- Protocol Development (Korean, English)
- CSR Development (Korean, English)
• DM/STAT/CSR
- Data Management (DM) (EDC & paper-based)
- Statistical Services
- Clinical Study Report (CSR) (Korean, English)
- CRF Development (Paper & e-Contents)
• RA/SSU
- Regulatory Affairs (IND)
- Feasibility (Site / Investigator Selection)
- PSSV (Pre-Study Site Visit) : Site Qualification Visit
- IRB Submission
- CTA (Clinical Trial Agreement)
- IP / non IP Import
- GSP (Good Supply Practice) Service
• PMS/Observational Studies
- Post Marketing Surveillance (PMS)
- Observational / Epidemiological Studies
• Drug Registration Service
- Registration Strategy
- NDA Package Preparation / Submission
- Reimbursement Package / Submission
33
MH2 BIOCHEMICAL CO., LTD.
Company Introduction
During last 10 years we have supplied some amino acids such as
Ornithine, Citrulline and GABA through fermentation and enzymatic
processes as ingredients of food and dietary supplements,
meanwhile we have worked to secure the sustainable processes of
BIOCATALYSIS
unnatural amino acids and chiral intermediates by using ω(FOOD ADDITIVE, transaminase, lipase and etc. We are pleased to introduce these new
HEALTH FOOD, products to the customers
COSMETICS)
Main Products
• Ingredients : L-Ornithine, L-Citrulline, GABA, L-Serine, D-Alanine,
D-Glutamic acid, D-Aspartic acid, D-Arginine
• Anti-hangover (finished good): CHUISUN, CHOSUN
• Beauty food (Finished good): Beauty Carotene
www.mh2.co.kr
□
www.nbms.co.kr
□
Company Introduction
NBM Inc. is an innovative company for the production of
recombinant proteins such as growth factors, antibodies, cytokines,
and proteases by using plant. The company is also advancing to
produce recombinant biopharmaceutical proteins development
programs. NBM Inc. is expanding to cosmetics and pharmaceutical
industry in the global market with its progressive products and is
highly acclaimed at home and abroad because of its technology
competitiveness. Our product portfolio has expanded steadily to
meet the needs of our customers with biorisk-free growth factors
and cytokines.
34
NBM INC.
Cosmetic
Ingredients,
Recombinant
Proteins(Medical
Materials),
Functional Materials
Main Products
NBM Inc. has produced a range of high-grade, animal-free and
endotoxin-free growth factors produced from rice cell culture, which
have recently been recognized as the next generation’s new
materials for cosmetics. The high quality Growth factors & Cytokines
of NBM Inc. satisfy cosmetic manufacturers and end customer with
high safety and efficacy. NBM Inc. is instead committed to produce
high quality recombinant proteins for cosmetic ingredients which will
provide benefits directly to the consumer by using plants as bioreactors.
NBM Inc. can produce from milligrams to kilograms of the high
quality recombinant protein to satisfy our client’s needs.
• Rice Cell-produced Cosmetic Ingredients
- hEGF, hFGFa, hFGFb, hVEGF-165, hKGF, hGM-CSF
High purity grade | Animal Free | Mouse Free | Bacteria Free |
Endotoxin Free
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
Company Introduction
SAMCHUN GROUP consists of big three axes, Samchun Chemical
Co., Samchun Pure Chemical Co. and Samchun Development Co.
These axes are connected with the networks of four branch offices
organically, establishing an integrated system to tackle and resolve
any pending issue cooperatively. This cooperative system creates
many advantages: cost reduction, high efficiency, high productivity
and smooth performance of jobs assigned. Samchun Chemical is
focused on sales, international business, planning, corporate
management, while Samchun Pure Chemical undertakes
manufacturing and logistics. Each branch office deals with subdealers and specific customers for reagent chemicals, laboratory
equipment and supplies.
35
Main Products
We have broadened the product range of SAMCHUN brand upto
over 1,500 items and keep in stock various foreign brands of over
19,000 items, which are available from our stocks any time. We
have also set up an efficient, well-organized logistics systems and
24-hour delivery system, an optimal delivery networks of many
branch offices to better serve customers’ various needs. You can
get satisfactory solutions from Samchun with one phone call if you
have any question or requirement for your R&D projects. In
addition to the products covered by our catalog, we offer custommanufacturing/synthesis services. You are welcome to contact,
visit us any time.
SAMCHUN PURE CHEMICAL
www.samchun.com
□
www.shinpoong.co.kr
□
www.skchemicals.com
□
• Reagent Chemicals
- General reagents
- Specialty reagents
- Various imported reagents
• Equipment & Instruments
- ADVANTEC
- Whatman
- Products of other Japanese makers
• Synthesis Raw Materials
- About 300 manufactured items (custom-manufacturing offered)
• Pharmaceutical Raw Materials
- About 150 regular items including over 30 times of surfactents,
food additives, cosmetic raw matericals (skin moisturizer),
fragrance designs
Main Products
1. Pyramax film-coated tablet 180mg/60mg
1) API : pyronaridine tetraphosphate / Artesunate
2) Indications : the treatment of acute, uncomplicated malaria
infection caused by Plasmodium falciparum or by Plasmodium vivax.
36
2. Loxfen CR tablet 90mg
1) API : Loxoprofen sodium
Rheumatoid arthritis 2) Indications : Chronic rheumatoid arthritis, osteoarthritis, lumbago,
and osteoporosis, scapular periarthritis, neck-scaplular syndrome, analgesic and antiSHIN POONG PHARM. CO., LTD. Blood circulation
inflammation of post-operation, post-trauma and post-arrachement.
system,
Infectious disease R&D Pipeline
[NCE]
SP-8203 : Stroke (Phase I)
SP-35454 : Osteoporosis (Preclinical)
JSH-2236 : Heart failure (Preclinical)
[IMD]
AC-001 : Hypertension (Phase II)
ER-001 : Hyperlipidemia (Phase I)
37
SK CHEMICALS CO., LTD.
NCE, Herbal
medicine, Vaccine,
IMD, Biologics,
Plasma products
Company Introduction
SK Chemical is a member company of SK Group, the third largest
company group in Korea. Since founded in 1969, SK Chemicals
has focused on the development of drug products targeting the
diseases with unmet treatment needs in order to fulfill its vision ;
“Healthcare and Earthcare”. The R&D area of SK Chemicals covers
a broad range of product lines, including new chemical entities,
new herbal extract drugs, reformulated generics, vaccines and
blood products. Owing to its continuous efforts on R&D, SK
Chemicals was able to develop three new chemical entities(NCEs),
novel drug delivery system(DDS) flat form technologies,
recombinant DNA technology and in-house premium vaccines. On
the basis of this strong R&D capability together with its outstanding
marketing operations, SK Chemicals was selected as a member of
the Korea Innovative Pharmaceutical Company.
Main Products
• Sunpla® Injection
• Mvix® S ODF, Mvix® Tablet
• Joins® Tablet
• Influenza Vaccine
• TRAST® patch
R&D Pipeline
• NCE : Fibrosis, Diabetes
• Vaccine : Influenza, PCV, Varicella
• Biologics : Recombinant factor VIII
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
• Plasma products : Immunoglobulin injection(Hepatitis B)
New Active Substances
• Heptaplatin(third-generation platinum anti-cancer drug) : the
Korean’s first new drug
• Mirodenafil(erectile dysfunction treatment) : the worlds’ highest
score in the International Index of Erectile Function (IIEF)
Introduction
The “ fine chemical industry ” is drastically rising as the next
generation´;s industry that comes with high added value. To solve
the weaknesses and problems in the chemical industry of Ulsan ,
and to be a Mecca of the Korean chemical industry in the next
generation, the Fine Chemical and Material Technical Institute is
preparing its ambitious plans.
38
ULSAN TECHNOPARK
www.camti.or.kr
□
www.wellcorp.co.kr
□
www.yuhan.co.kr
□
www.yuyu.co.kr
□
Business Area
• Consulting
- Conceptual Design
- GMP Consulting
39
WELL E&C CO., LTD.
Glass Reactor,
TCU(Temperature
Control Unit)
• Engineering
- Pilot Plant
- Basic / Detail Engineering
- Turnkey
• APIs
- Raw Material
- Intermediate
- R&D Center
44
45
YUHAN CORPORATION
YUYU PHARMA INC.
Gastrointestinal
disease,
Cardiovascular
disease,
Metabolic disease
Company Introduction
Founded in 1926 with the mission of supporting South Korea by
enhancing the quality of life for all people, Yuhan has been
providing high quality medicines for the last 85 years as one of the
leading pharmaceutical companies in South Korea. Since its
foundation, Yuhan has set the foremost priority to provide the best
medicines by building its R&D. In 2005, Yuhan moved its central
research to Giheung, Gyeonggi-do, and opened the largest R&D
center in the South Korea pharmaceutical industry. With state-ofthe-art facilities, Yuhan is committed to deliver advanced and
innovative medicines to enhance quality of life. Yuhan is focusing its
R&D capabilities on developing new chemical entities, herbal
medicines, market-oriented IMDs(Incrementally modified drugs),
and APIs/intermediates for overseas markets.
Main Products
• Piperacillin Monohydrate
• CMO-HIV New Drug
• Ribavirin
• CMO-HCV New Drug.
• PEG-NHS
• CMO-HIV New Drug
• CMO- HIV New Drug
• Cilostazol
• PEG-Thiol
• Levofloxacin
Company Introduction
YuYu Pharma, Inc. was founded in 1941. Through the development
and distribution of new drugs, medicines, and health services that
aim to improve peoples’ health and quality of life, YuYu is growing
into a company with a history of “70 years of success” We have
developed a number of high-grade prescription medicines such as
Tanamin (medicine for dementia and peripheral circulatory
disturbance), Maxmarvil (new medicine for osteoporosis treatment),
CLID (thromboembolectomy treatment), and Umckamin (medicine
for asthma and respiratory infection). We market each of these
products through scientific marketing to maximize coverage and
efficiency. Maxmarvil, the nation’s tenth new medicine and the first
combined new medicine, is taken to treat osteoporosis and is widely
favored by patients and doctors due to its high efficacy and safety.
YuYu also has the distinction of having developed the nation’s
second combined new medicine, YUCILD, a cure for stroke. For
general medicines, we have Yupan-C (Vitamin C), Venapollo
(multivitamin for nearly 50 years), Venoplus Gel (bruise ointment),
Physiomer (nasal cavity washer), and Noiromin (plant
antidepressant), which are available at any pharmacy.
Main Products
• Prescription
KOREA PHARM 2015 HOSTED BUYER PROGRAM
21
Tue. -24 Fri.
APRIL, KINTEX 1, KOREA
- Osteoporosis Drugs
- BrainBone Metabolism-Hypocalcemia Improvement Drug
- Cerebral & Peripheral Circulatory Disturbance Drug
- Tromboembolism Drugs
- Respiratory Organ Drugs
- Hypertension Drugs
- Other Circulatory System Drugs
- Hyperlipidemia Drugs
- Antibiotics
- Pulmonary Tuberculosis Therapy Drug
- Migraine Drugs
- Arthrifuge
- Antipyretic Analgesic and Anti-Inflammatory Agent
- Diabetic Neuropathy Therapy Drug
- Skeletal Muscle Relaxant
- Antihistamine
- Urinary System (Organ) Drugs
- Eczematous Dermatitis Drugs
• Non-Prescription
- Physiomer Baby Nasal Cavity Cleaning Solution
- Physiomer Kids Nasal Cavity Cleaning Solution
- Physiomer Gentle Nasal Cavity Cleaning Solution
- Physiomer Strong Nasal Cavity Cleaning Solution
- Physiomer Pump Mist Nasal Cavity Cleaning Solution
- VENOPLUS Gel
- TANAMINE Tablet
- NOIROMIN Tablet
- Venapollo-Extra Soft Capsule
- YUTRI Gel
- Barosofen Soft Capsule
- YU-Achuoo Capsule
- Sokpyunase Tablet
- Relax Tablet
- Tanasol Solution
- Yupan-C 1000 Plus Tablet
- Tuguard Soft Capsule
• Quai Drugs
- Yupan-C Tablet
- Yupan-C Pop
- BB White Premium Tablet
• Health Supplement
- Formoline
- Hi-Q
- Lycopene
- YuYu Caldi
- EyeYou Lutein Zeaxanthin
- BB White Collagen
- Miffy Vita 1000T